AAAAAA

   
Results: 1-7 |
Results: 7
The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons
Authors: Weiss, C Preston, AR Oh, MM Schwarz, RD Welty, D Disterhoft, JF
Citation: C. Weiss et al., The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons, J NEUROSC, 20(2), 2000, pp. 783-790
Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice
Authors: Kane, MD Lipinski, WJ Callahan, MJ Bian, F Durham, RA Schwarz, RD Roher, AE Walker, LC
Citation: Md. Kane et al., Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice, J NEUROSC, 20(10), 2000, pp. 3606-3611
Latent structure analysis of classification errors in screening and clinical diagnosis: An alternative to classification analysis
Authors: Bergan, JR Schwarz, RD Reddy, LA
Citation: Jr. Bergan et al., Latent structure analysis of classification errors in screening and clinical diagnosis: An alternative to classification analysis, APPL PSYC M, 23(1), 1999, pp. 69-86
Milameline (CI-979/RU35926): A muscarinic receptor agonist with cognition-activating properties: Biochemical and in vivo characterization
Authors: Schwarz, RD Callahan, MJ Coughenour, LL Dickerson, MR Kinsora, JJ Lipinski, WJ Raby, CA Spencer, CJ Tecle, H
Citation: Rd. Schwarz et al., Milameline (CI-979/RU35926): A muscarinic receptor agonist with cognition-activating properties: Biochemical and in vivo characterization, J PHARM EXP, 291(2), 1999, pp. 812-822
Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction
Authors: Kane, MD Schwarz, RD St Pierre, L Watson, MD Emmerling, MR Boxer, PA Walker, GK
Citation: Md. Kane et al., Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, J NEUROCHEM, 72(5), 1999, pp. 1939-1947
Identification and characterization of m1 selective muscarinic receptor antagonists
Authors: Augelli-Szafran, CE Blankley, CJ Jaen, JC Moreland, DW Nelson, CB Penvose-Yi, JR Schwarz, RD Thomas, AJ
Citation: Ce. Augelli-szafran et al., Identification and characterization of m1 selective muscarinic receptor antagonists, J MED CHEM, 42(3), 1999, pp. 356-363
Design and synthesis of novel quinoxaline-2,3-dione AMPA/Gly(N) receptor antagonists: Amino acid derivatives
Authors: Nikam, SS Cordon, JJ Ortwine, DF Heimbach, TH Blackburn, AC Vartanian, MG Nelson, CB Schwarz, RD Boxer, PA Rafferty, MF
Citation: Ss. Nikam et al., Design and synthesis of novel quinoxaline-2,3-dione AMPA/Gly(N) receptor antagonists: Amino acid derivatives, J MED CHEM, 42(12), 1999, pp. 2266-2271
Risultati: 1-7 |